期刊文献+

miR-1266靶向DAB2IP调控肝癌细胞的增殖和凋亡 被引量:1

miR-1266 targets DAB2IP to regulate the proliferation and apoptosis of hepatocellular carcinoma cells
下载PDF
导出
摘要 目的探讨miR-1266对肝癌细胞增殖和凋亡的影响及其调控机制。方法选取西安市第八医院2018年1月至2018年10月收治的40例肝癌患者,利用实时荧光定量PCR(qRT-PCR)检测肝癌组织中miR-1266和DAB2IP的表达水平并分析其相关性;利用生物信息学网站预测miR-1266潜在靶基因DAB2IP,双荧光素酶实验进行验证;利用脂质体转染技术向在肝癌HepG2细胞中转染miR-1266 mimics、miR-1266 mimics+pcDNA-DAB2IP,qRT-PCR验证转染效率;利用Western blotting检测转染后细胞中DAB2IP蛋白表达水平;CCK-8实验和流式细胞仪分别检测转染后细胞的增殖和凋亡情况。结果qRT-PCR结果显示,肝癌组织中miR-1266表达上调,而DAB2IP表达下调,两者表达水平呈负相关。生物信息学预测miR-1266的靶基因可能是DAB2IP,双荧光素酶报告实验显示,DAB2IP是miR-1266的靶基因。Western blotting实验结果显示,转染miR-1266 mimics显著降低了DAB2IP蛋白表达,miR-1266 mimics+pcDNA-DAB2IP共转染恢复了DAB2IP蛋白表达。CCK-8增殖实验和流式细胞仪结果显示,转染miR-1266 mimics显著促进了HepG2细胞增殖,抑制了细胞凋亡,miR-1266 mimics+pcDNA-DAB2IP共转染逆转了上述现象。结论肝癌组织中miR-1266表达上调,DAB2IP表达下调;miR-1266通过靶向下调DAB2IP表达促进肝癌细胞增殖、抑制细胞凋亡。 Objective To investigate the effect of miR-1266 on proliferation and apoptosis of hepatocellular carcinoma cells and its regulatory mechanism.Methods Forty hepatocellular carcinoma patients were selected from Jun.2018 to Oct.2018 in the Eighth Hospital of Xi’an.Real-time fluorescence quantitative PCR(qRT-PCR)was used to detect the expression levels of miR-1266 and DAB2 IP in hepatocellular carcinoma tissues and analyze its correlation.Bioinformatics website was used to predict the potential target gene DAB2 IP of miR-1266,and double luciferase experiment was used to verify it.Liposome transfection technology was used to transfect miR-1266 mimics,miR-1266 mimics+pcDNA-DAB2 IP into HepG2 cells,and qRT-PCR was used to verify the transfection efficiency.The expression of DAB2 IP protein was detected by Western blotting,and the proliferation and apoptosis of the transfected cells were detected by CCK-8 assay and flow cytometry respectively.Results The results of qRT-PCR showed that the expression of miR-1266 was up-regulated,while the expression of DAB2 IP was down-regulated in hepatocellular carcinoma tissues,and the expression levels of both were negatively correlated.Bioinformatics predicted that the target gene of miR-1266 might be DAB2 IP,and double luciferase report experiments showed that DAB2 IP was a target gene of miR-1266.The results of Western blotting showed that transfection of miR-1266 mimics significantly reduced DAB2 IP protein expression,and co-transfection of miR-1266 mimics+pcDNA-DAB2 IP restored DAB2 IP protein expression.The results of CCK-8 proliferation experiments and flow cytometry showed that transfection of miR-1266 mimics significantly promoted HepG2 cell proliferation and inhibited apoptosis,co-transfection of miR-1266 mimics+pcDNA-DAB2 IP reversed the above phenomenon.Conclusion The expression of miR-1266 is up-regulated,while the expression of DAB2 IP is down-regulated in hepatocellular carcinoma tissues;miR-1266 promotes the proliferation and inhibits apoptosis of hepatocellular carcinomacells by targeting down-regulation of DAB2 IP expression.
作者 吴晓庆 万红 杨璞叶 钱宏波 靳稳妮 兰琳 WU Xiaoqing;WAN Hong;YANG Puye;QIAN Hongbo;JIN Wenni;LAN Lin(Department of Hepatology,the Eighth Hospital of Xi’an,Xi’an 710061;Department of Infection,the Second People’s Hospital of Lanzhou City;Department of Integrated Traditional Chinese and Western Medicine,the Eighth Hospital of Xi’an;Department of Laboratory,the Eighth Hospital of Xi’an,China)
出处 《胃肠病学和肝病学杂志》 CAS 2020年第10期1179-1184,共6页 Chinese Journal of Gastroenterology and Hepatology
关键词 miR-1266 肝癌 DAB2IP 增殖 凋亡 miR-126 Hepatocellular carcinoma DAB2IP Proliferation Apoptosis
  • 相关文献

参考文献3

二级参考文献27

  • 1Yasunori Minami,Masatoshi Kudo.Radiofrequency ablation of hepatocellular carcinoma:Current status[J].World Journal of Radiology,2010,2(11):417-424. 被引量:40
  • 2Andy Trotti,A.Dimitrios Colevas,Ann Setser,Valerie Rusch,David Jaques,Volker Budach,Corey Langer,Barbara Murphy,Richard Cumberlin,C.Norman Coleman,Philip Rubin.CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment[J]. Seminars in Radiation Oncology . 2003 (3)
  • 3Feng Xia,Wan-Yee Lau,Yanmin Xu,Lin Wu,Cheng Qian,Ping Bie.Does Hepatic Ischemia–Reperfusion Injury Induced by Hepatic Pedicle Clamping Affect Survival after Partial Hepatectomy for Hepatocellular Carcinoma?[J].World Journal of Surgery.2013(1)
  • 4Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncology.2009(1)
  • 5Hashem B. El–Serag,K. Lenhard Rudolph.Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis[J].Gastroenterology.2007(7)
  • 6Guido Torzilli,Jacques Belghiti,Norihiro Kokudo,Tadatoshi Takayama,Lorenzo Capussotti,Gennaro Nuzzo,Jean-Nicolas Vauthey,Michael A. Choti,Eduardo De Santibanes,Matteo Donadon,Emanuela Morenghi,Masatoshi Makuuchi.A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations?: An Observational Study of the HCC East-West Study Group[J].Annals of Surgery.2013(5)
  • 7Takeaki Ishizawa,Kiyoshi Hasegawa,Taku Aoki,Michiro Takahashi,Yosuke Inoue,Keiji Sano,Hiroshi Imamura,Yasuhiko Sugawara,Norihiro Kokudo,Masatoshi Makuuchi.Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma[J]. Gastroenterology . 2008 (7)
  • 8K Urata,Y Hashikura,T Ikegami,M Terada,S Kawasaki.Standard liver volume in adults[J]. Transplantation Proceedings . 2000 (7)
  • 9Masami Minagawa,Masatoshi Makuuchi,Tadatoshi Takayama,Kuni Ohtomo.Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus[J]. Annals of Surgery . 2001 (3)
  • 10Josep M Llovet,Andrew Burroughs,Jordi Bruix.??Hepatocellular carcinoma(J)The Lancet . 2003 (9399)

共引文献67

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部